Polomar Health Services, Inc. operates as a retail compounding pharmacy in the United States. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; Tofacitinib, it treats rheumatoid arthritis by inhibiting JAK to reduce inflammation and pain; Semaglutide GLP-1, which regulates blood sugar, appetite, and weight in diabetes management; and compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker's nevus, vitiligo, and other skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.
Frequently asked questions
What sector does PMHS (PMHS) operate in?
PMHS belongs to the Other sector and operates in the Pharmaceutical Retailers industry.
What is PMHS (PMHS) current stock price?
As of the latest data, PMHS stock price is $0.15, with a previous close of $0.13. PMHS gained $0.02 in the last trading session, representing a 15.38% increase.
What is PMHS (PMHS) current market capitalization?
PMHS market cap is approximately 4.26 million.
What is PMHS (PMHS) Earnings Per Share (EPS)?
The trailing EPS is -$0.35.
What is PMHS (PMHS) EBITDA?
PMHS EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 227.87 thousand.
Does PMHS (PMHS) pay dividends?
No. PMHS does not pay a dividend.
What is PMHS (PMHS) beta (volatility) score?
PMHS has a beta of -0.633, indicating lower volatility than the overall market.